University of Khartoum

Outcomes of sclerotherapy among esophageal varices patients in Gezira center for GIT endoscopy and laparoscopic surgery 2001 - 2010 Gezira, Sudan

Outcomes of sclerotherapy among esophageal varices patients in Gezira center for GIT endoscopy and laparoscopic surgery 2001 - 2010 Gezira, Sudan

Show full item record

Title: Outcomes of sclerotherapy among esophageal varices patients in Gezira center for GIT endoscopy and laparoscopic surgery 2001 - 2010 Gezira, Sudan
Author: Elbadawi, Abdulateef Sayed Ahmed; Suleiman, Emadeldin Aljak; Mohammed, Moawia Elballal; Elmukashfi, Taha Ahmed
Abstract: Background: Endoscopic variceal sclerotherapy (EVS) is a procedure used to treat esophageal bleeding. The procedure involves introducing a flexible endoscope into the esophagus to inject sclerosing agents into the varices. Varices are enlarged veins on the esophagus that bleed and have fatal effects in up to 50 percent of patients. The sclerosing agent destroys varices and slows thrombosis, which stops esophageal bleeding. Methods: This study was designed as a retrospective descriptive facility based aimed to evaluate the outcome of sclerotherapy delivered to patients with bleeding esophageal varices during 2001 - 2010 in Gezira center for GIT endoscopy and laparoscopic surgery. Records of 1140 patients - representing all esophageal varices patients attended to the center since 2001 -2010 were carefully reviewed. Results: The result of this study showed that 15.2 % of sclerotherapy treated patients developed bleeding after completing their sessions of sclerotherapy while the remaining patients had no future complications. Discussion: Most of sclerotherapy treated patients reported no complication while one in each seven of them complained of rebleeding and one in each fifteen of them complained of retrosternal chest pain. These results are compatible with the literature which show that significant complications will develop in 10% to 15% of patients treated with sclerotherapy. These results are also considered to have low rate when it was compared with another study carried out in Britain which showed that recurrent variceal bleeding developed in 31% of sclerotherapy treated patients. Conclusion: The conclusion of this study is that rebleeding after treatment with Sclerotherapy was the commonest complication. Poor follow up rate, late seeking of medical care and incompleteness of Sclerotherapy sessions were obviously noticed
URI: http://khartoumspace.uofk.edu/123456789/16301
Date: 2013-10


Files in this item

Files Size Format View

This item appears in the following Collection(s)

Show full item record

Share

Search DSpace


Browse

My Account